Avicanna Inc. (TSX:AVCN)
0.1500
0.00 (0.00%)
Apr 10, 2026, 3:59 PM EST
Avicanna Revenue
In the year 2025, Avicanna had annual revenue of 25.48M CAD with 0.08% growth. Avicanna had revenue of 6.60M in the quarter ending December 31, 2025, a decrease of -0.25%.
Revenue
25.48M
Revenue Growth
+0.08%
P/S Ratio
0.74
Revenue / Employee
227.49K
Employees
112
Market Cap
18.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.48M | 19.50K | 0.08% |
| Dec 31, 2024 | 25.46M | 8.67M | 51.62% |
| Dec 31, 2023 | 16.79M | 12.74M | 314.82% |
| Dec 31, 2022 | 4.05M | 778.97K | 23.83% |
| Dec 31, 2021 | 3.27M | 1.70M | 108.20% |
| Dec 31, 2020 | 1.57M | 1.40M | 833.16% |
| Dec 31, 2019 | 168.25K | 50.28K | 42.62% |
| Dec 31, 2018 | 117.97K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| 1CM Inc. | 75.01M |
| MediPharm Labs | 45.12M |
| Medicure | 26.21M |
| Crescita Therapeutics | 21.12M |
| Greenway Greenhouse Cannabis | 9.13M |
| Red Light Holland | 4.17M |
| Mountain Valley MD Holdings | 57.00K |
Avicanna News
- 5 days ago - Avicanna Announces Changes to its Board of Directors - GlobeNewsWire
- 10 days ago - Avicanna Reports Full Year 2025 Audited Financial Statements - GlobeNewsWire
- 16 days ago - Avicanna Subsidiary SMGH Completes First Commercial Export to Australia - GlobeNewsWire
- 26 days ago - Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial - GlobeNewsWire
- 2 months ago - Avicanna Announces Closing of Non-Brokered Private Placement - GlobeNewsWire
- 2 months ago - Avicanna Announces Medical Cannabis Real World Evidence Results and Publication - GlobeNewsWire
- 4 months ago - Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update - GlobeNewsWire
- 5 months ago - Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform - GlobeNewsWire